(a)
Study— The Comptroller General of the United States, in consultation with the Secretary of Health and Human Services, the Secretary of Defense, the Administrator of the Centers for Medicare & Medicaid Services, the Director of the National Institutes of Health, and the Commissioner of Food and Drugs, shall conduct a study on best practices in use by Federal departments and agencies to reduce opioid usage following a medical procedure that is conducted, funded, or otherwise supported by such departments and agencies.
(b)
Topics— The study required by subsection (a)—
(1)
shall—
(A)
include analysis of the research that has been, and is being, conducted or supported on reducing opioid usage following medical procedures described in subsection (a);
(B)
disaggregate such analysis according to whether the medical procedure is a short-term medical procedure or a long-term medical procedure; and
(C)
take into consideration—
(i)
the costs associated with using the best practices described in subsection (a) relative to the costs of not using such best practices; and
(ii)
the rates of addiction to opioids associated with using the best practices described in subsection (a) relative to the rates of addiction to opioids associated with not using such best practices; and
(2)
shall include analysis of—
(A)
gaps that have been identified by Federal officials with respect to the costs and rates described in clauses (i) and (ii) of paragraph (1)(C) relative to adult, young adult, and adolescent populations; and
(B)
justifications offered by such officials for such gaps.
(c)
Report— Not later than 2 years after the date of enactment of this Act, the Comptroller General shall submit to the appropriate committees of the Congress a report containing the results of the study conducted under subsection (a), including—
(1)
a summary of the findings of the study;
(2)
recommendations based on the results of the study, including recommendations for such areas of research and legislative and administrative action as the Comptroller General determines appropriate; and
(3)
recommendations on educating health care providers about the findings of the study.
(d)
Definitions— In this Act:
(1)
The term short-term medical procedure means a medical procedure with a recovery time of less than 30 calendar days.
(2)
The term long-term medical procedure means a medical procedure with a recovery time of 30 calendar days or more.